Literature DB >> 11278545

Differentiated 3T3L1 adipocytes are composed of heterogenous cell populations with distinct receptor tyrosine kinase signaling properties.

S Shigematsu1, S L Miller, J E Pessin.   

Abstract

Various studies have demonstrated that the platelet-derived growth factor (PDGF) receptor in adipocytes can activate PI 3-kinase activity without affecting insulin-responsive glucose transporter (GLUT4) translocation. To investigate this phenomenon of receptor signaling specificity, we utilized single cell analysis to determine the cellular distribution and signaling properties of PDGF and insulin in differentiated 3T3L1 adipocytes. The insulin receptor was highly expressed in a large percentage of the cell population (>95%) that also expressed caveolin 2 and GLUT4 with very low levels of the PDGF receptor. In contrast, the PDGF receptor was only expressed in approximately 10% of the differentiated 3T3L1 cell population with relatively low levels of the insulin receptor, caveolin 2, and GLUT4. Consistent with this observation, insulin stimulated the phosphorylation of Akt in the caveolin 2- and GLUT4-positive cells, whereas PDGF primarily stimulated Akt phosphorylation in the caveolin 2- and GLUT4-negative cell population. Furthermore, transfection of the PDGF receptor in the insulin receptor-, GLUT4-, and caveolin 2-positive cells resulted in the ability of PDGF to stimulate GLUT4 translocation. These data demonstrate that differentiated 3T3L1 adipocytes are not a homogeneous population of cells, and the lack of PDGF receptor expression in the GLUT4-positive cell population accounts for the inability of the endogenous PDGF receptor to activate GLUT4 translocation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278545     DOI: 10.1074/jbc.M009684200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Cell-autonomous heterogeneity of nutrient uptake in white adipose tissue of rhesus macaques.

Authors:  Oleg Varlamov; Michael Chu; Anda Cornea; Harini Sampath; Charles T Roberts
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

2.  Subcutaneous adipose tissue imaging of human obesity reveals two types of adipocyte membranes: Insulin-responsive and -nonresponsive.

Authors:  Chad D McCormick; Hang N Waters; Ludmila Bezrukov; Roxana Taginya; Viraj Parikh; Ginikanwa I Onyekaba; Jordan A Levine; Andrew P Demidowich; Jack A Yanovski; Paul S Blank; Joshua Zimmerberg
Journal:  J Biol Chem       Date:  2018-07-13       Impact factor: 5.157

3.  Nelfinavir-induced insulin resistance is associated with impaired plasma membrane recruitment of the PI 3-kinase effectors Akt/PKB and PKC-zeta.

Authors:  R Ben-Romano; A Rudich; A Tirosh; R Potashnik; T Sasaoka; K Riesenberg; F Schlaeffer; N Bashan
Journal:  Diabetologia       Date:  2004-05-28       Impact factor: 10.122

4.  A novel RNAi lethality rescue screen to identify regulators of adipogenesis.

Authors:  Olivier van Beekum; Yuan Gao; Ruud Berger; Arjen Koppen; Eric Kalkhoven
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

5.  Diverse repertoire of human adipocyte subtypes develops from transcriptionally distinct mesenchymal progenitor cells.

Authors:  So Yun Min; Anand Desai; Zinger Yang; Agastya Sharma; Tiffany DeSouza; Ryan M J Genga; Alper Kucukural; Lawrence M Lifshitz; Søren Nielsen; Camilla Scheele; René Maehr; Manuel Garber; Silvia Corvera
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-16       Impact factor: 11.205

6.  Heterogeneity in the physiological states and pharmacological responses of differentiating 3T3-L1 preadipocytes.

Authors:  Lit-Hsin Loo; Hai-Jui Lin; Dinesh K Singh; Kathleen M Lyons; Steven J Altschuler; Lani F Wu
Journal:  J Cell Biol       Date:  2009-10-26       Impact factor: 10.539

7.  Single-cell profiling reveals the origin of phenotypic variability in adipogenesis.

Authors:  Thuc T Le; Ji-Xin Cheng
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.